These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29180607)

  • 1. Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.
    Chang MT; Penson A; Desai NB; Socci ND; Shen R; Seshan VE; Kundra R; Abeshouse A; Viale A; Cha EK; Hao X; Reuter VE; Rudin CM; Bochner BH; Rosenberg JE; Bajorin DF; Schultz N; Berger MF; Iyer G; Solit DB; Al-Ahmadie HA; Taylor BS
    Clin Cancer Res; 2018 Apr; 24(8):1965-1973. PubMed ID: 29180607
    [No Abstract]   [Full Text] [Related]  

  • 2. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
    Wang L; Smith BA; Balanis NG; Tsai BL; Nguyen K; Cheng MW; Obusan MB; Esedebe FN; Patel SJ; Zhang H; Clark PM; Sisk AE; Said JW; Huang J; Graeber TG; Witte ON; Chin AI; Park JW
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):563-572. PubMed ID: 31871155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews.
    Chen Z; Liu Q; Chen R; Liu Z; Li M; Ling Q; Wu L; Yang J; Liu X; Wang T; Hu Z; Guo X; Wang S; Yang W; Liu J
    World J Surg Oncol; 2017 Jan; 15(1):33. PubMed ID: 28125986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Cell Neuroendocrine Tumors: Cell State Trumps the Oncogenic Driver.
    Oser MG; Jänne PA
    Clin Cancer Res; 2018 Apr; 24(8):1775-1776. PubMed ID: 29374051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell carcinoma of the bladder: the characteristics of molecular alterations, treatment, and follow-up.
    Wang Y; Li Q; Wang J; Tong M; Xing H; Xue Y; Pan H; Huang C; Li D
    Med Oncol; 2019 Oct; 36(12):98. PubMed ID: 31664527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
    Hoffman-Censits J; Choi W; Pal S; Trabulsi E; Kelly WK; Hahn NM; McConkey D; Comperat E; Matoso A; Cussenot O; Cancel-Tassin G; Fong MHY; Ross J; Madison R; Ali S
    Eur Urol Oncol; 2021 Apr; 4(2):297-300. PubMed ID: 32061548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma.
    Priemer DS; Wang M; Zhang S; Lopez-Beltran A; Kouba E; Montironi R; Davidson DD; MacLennan GT; Wang L; Osunkoya AO; Deng Y; Emerson RE; Cheng L
    Eur Urol Focus; 2018 Dec; 4(6):880-888. PubMed ID: 28753872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome.
    van de Kamp M; Meijer R; Pos F; Kerst M; van Werkhoven E; van Rhijn B; Horenblas S; Bex A
    Urol Oncol; 2018 Jun; 36(6):307.e1-307.e8. PubMed ID: 29580697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Small cell neuroendocrine carcinoma of the urinary bladder].
    Milica CR; Dragan MB; Aleksandar VM; Cane TDz; Dundjerović DM; Vjestica JM; Jasmina ML
    Acta Chir Iugosl; 2013; 60(1):95-7. PubMed ID: 24669571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of early stage small cell bladder cancer is not always dismal.
    Lim JH; Sundar S
    ESMO Open; 2019; 4(6):e000559. PubMed ID: 31798978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.
    Shen P; Jing Y; Zhang R; Cai MC; Ma P; Chen H; Zhuang G
    Oncogene; 2018 May; 37(22):3039-3044. PubMed ID: 29535424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
    Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.
    Fernández-Aceñero MJ; Córdova S; Manzarbeitia F; Medina C
    Pathol Oncol Res; 2011 Sep; 17(3):519-23. PubMed ID: 21203907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
    Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
    J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of bladder cancer genomics: What have we learned and how can we use it?
    Audenet F; Attalla K; Sfakianos JP
    Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Weyerer V; Eckstein M; Strissel PL; Wullweber A; Lange F; Tögel L; Geppert CI; Sikic D; Taubert H; Wach S; Wullich B; Hartmann A; Stoehr R; Giedl J
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    Naito A; Taguchi S; Nakagawa T; Matsumoto A; Nagase Y; Tabata M; Miyakawa J; Suzuki M; Nishimatsu H; Enomoto Y; Takahashi S; Okaneya T; Yamada D; Tachikawa T; Minowada S; Fujimura T; Fukuhara H; Kume H; Homma Y
    World J Urol; 2017 Jan; 35(1):97-103. PubMed ID: 27180266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.